| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/30/2005 | CA2550581A1 Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation |
| 06/30/2005 | CA2550013A1 Bactericide against streptococcus mutans and streptococcus sobrinus |
| 06/30/2005 | CA2549874A1 Antibacterial macrocycles with substituted biphenyl |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549098A1 Hiv protease inhibiting compounds |
| 06/30/2005 | CA2549001A1 Rifamycin analogs and uses thereof |
| 06/30/2005 | CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548657A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548585A1 Treatment of viral infections |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547615A1 Remedy |
| 06/29/2005 | EP1547613A1 Medication and method for treating pathological syndrome |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546361A1 Auto-stimulating cells and method for making and using the same |
| 06/29/2005 | EP1546206A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 06/29/2005 | EP1546194A2 Therapeutic uspa1-derived peptides |
| 06/29/2005 | EP1546193A1 Pegylated t1249 polypeptide |
| 06/29/2005 | EP1546174A2 Methods and compositions for rna interference |
| 06/29/2005 | EP1546173A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 06/29/2005 | EP1546156A1 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/29/2005 | EP1546153A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors |
| 06/29/2005 | EP1546148A1 Therapeutic compounds based on pyrazolopyridine derivatives |
| 06/29/2005 | EP1546140A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 06/29/2005 | EP1546132A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 06/29/2005 | EP1546097A1 Pyrrole derivatives as antimycobacterial compounds |
| 06/29/2005 | EP1545619A2 Solution for ungual application |
| 06/29/2005 | EP1545614A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/29/2005 | EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2005 | EP1545584A2 Method for reducing morbidity and mortality in critically ill patients |
| 06/29/2005 | EP1545573A2 Asialo-interferons and the treatment of liver cancer |
| 06/29/2005 | EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 06/29/2005 | EP1545571A2 Herbs and herbal combinations useful for the treatment of microbial infections |
| 06/29/2005 | EP1545557A2 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 06/29/2005 | EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS |
| 06/29/2005 | EP1545539A2 Compositions for inducing increased levels of bgr-chemokines and methods of use therefor |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545530A1 Novel crystalline forms of gatifloxacin |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545518A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 06/29/2005 | EP1545516A2 Topical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 06/29/2005 | EP1545512A1 Methods for using gold (iii) complexes as anti-tumor and anti-hiv agents |
| 06/29/2005 | EP1545510A1 Substituted phenylindoles for the treatment of hiv |
| 06/29/2005 | EP1545490A1 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 06/29/2005 | EP1545483A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/29/2005 | EP1545465A1 Delayed release anti-viral product, use and formulation thereof |
| 06/29/2005 | EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 06/29/2005 | EP1545453A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/29/2005 | EP1545430A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2005 | EP1545429A2 Methods and compositions for treatment of dermal conditions |
| 06/29/2005 | EP1421093B1 Crystaline clindamycin free base |
| 06/29/2005 | EP1359917B1 Thioxazinoquinolones useful for the treatment of viral infections |
| 06/29/2005 | EP1347759B1 Antibacterial compounds |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1339400B1 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections |
| 06/29/2005 | EP1322648B1 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1237866B1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/29/2005 | EP1165077B1 Viral treatment |
| 06/29/2005 | EP1140114B1 Pharmaceutical formulations |
| 06/29/2005 | EP1121425B1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 06/29/2005 | EP1027362B1 2-halo-6-o-substituted ketolide derivatives |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/29/2005 | EP0773957B1 Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides |
| 06/29/2005 | CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633443A Arylation method for the functionalization of O-allyl erythromycin derivatives |
| 06/29/2005 | CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof |
| 06/29/2005 | CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/29/2005 | CN1633434A Imidazo[1, 2-a]pyridine derivative |
| 06/29/2005 | CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633417A Imidazolone derivatives for the treatment of viral diseases |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633415A Antibacterial mutilins |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633309A Method of radio-labelling biomolecules |
| 06/29/2005 | CN1633306A Viral inhibition by n-docosanol |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor |
| 06/29/2005 | CN1631898A Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof |
| 06/29/2005 | CN1631876A Preparation of sodium probenecid and potassium probenecid, compound injection prepared by sodium probenecid, potassium probenecid and beta-lactam antibiotics, and use thereof |
| 06/29/2005 | CN1631443A Targeted small interference RNA formulation for preventing and treating Hepatitis C and its preparation method |
| 06/29/2005 | CN1631442A Targeted small interference RNA formulation for treating viral Hepatitis B and its preparation |
| 06/29/2005 | CN1631441A Nucleic acid vaccine for preventing AIDS |
| 06/29/2005 | CN1631440A Recombined poxvirus vaccine for preventing AIDS |
| 06/29/2005 | CN1631439A Curtail hemagglutinin vaccine for preventing influenza virus and its preparing method |
| 06/29/2005 | CN1631438A 0157 bacterium gene engineering multivalence subunit vaccine of human and sensitive animals and its preparing method |
| 06/29/2005 | CN1631437A Method for extracting and synthesizing thymus microcapsule sustained release needle by PLGA |
| 06/29/2005 | CN1631436A Method for extracting and synthesizing alpha -2b microcapsule sustained release needle by PLGA |
| 06/29/2005 | CN1631431A Method for extracting ganoderma lucidum spore fat soluble active substance and its specified instrument for preparation |
| 06/29/2005 | CN1631422A Application of violet gold extractive in preparing process of medicine for resisting virus and bacteria |
| 06/29/2005 | CN1631410A Medicinal ointment for treating onychomycosis, flat wart and cindyloma acuminatum |
| 06/29/2005 | CN1631401A Medicine for preventing and treating SARS |